No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews. | Dig Dis Sci;67(1): 351-353, 2022 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews.

Li, Weizheng; Dong, Yongxue; Lei, Xianmei.

Li W; Yunfu People's Hospital, Yunfu, China. Weizhengli_0668@163.com.
Dong Y; Yunfu People's Hospital, Yunfu, China.
Lei X; Yunfu People's Hospital, Yunfu, China.

Dig Dis Sci ; 67(1): 351-353, 2022 01.

Article in English | MEDLINE | ID: covidwho-1391908

Subject(s)

COVID-19; Famotidine; Humans; Propensity Score; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Famotidine / COVID-19 Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Dig Dis Sci Year: 2022 Document Type: Article Affiliation country: S10620-021-07214-9

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Famotidine / COVID-19 Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Dig Dis Sci Year: 2022 Document Type: Article Affiliation country: S10620-021-07214-9